Sebastian Grosicki

13PUBLICATIONS
69CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Apr 23, 2026
ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

|Oct 29, 2025
A Rare Combination: Cold Agglutinin Disease Followed by Waldenström Macroglobulinemia-A Case of Early Treatment Response.

Anna Kozub, Aleksandra Nasiek, Natalia Bohun

|Jul 12, 2023
Elranatamab: a new promising BispAb in multiple myeloma treatment.

Sebastian Grosicki, Martyna Bednarczyk, Karolina Kociszewska

|Dec 23, 2022
The role of autophagy in acute myeloid leukemia development.

Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka

|Aug 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.

Claire N Harrison, Vikas K Gupta, Aaron T Gerds

Pageof 3

Frequent Collaborators

2 joint publications

Andrea Patriarca

2 joint publications

John Mascarenhas

2 joint publications

Claire N Harrison

2 joint publications

Martyna Bednarczyk